F.D.A. Revises Its Letter for Nonapproval of Drugs

Saturday, July 12, 2008 - 20:56 in Mathematics & Economics

Drug makers whose products are not ready for approval in the U.S. will soon get the word from regulators in a new format intended partly to avoid scaring investors.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net